Global /India /Healthcare /Drug Manufacturers - General /HIKAL
chevron_leftBack
Hikal Ltd. logo

Hikal Ltd.

HIKAL
NSE: HIKAL Delayed
189.25INR 0.1%
2.00 USD
As of 21 June 2026, Hikal Ltd. has a market cap of $246.7M USD, ranking #19793 globally and #1124 in India. It ranks #1777 in the Healthcare sector, and #648 in the Drug Manufacturers - General industry.
Global Rank
19793
Country Rank
1124
Sector Rank
1777
Industry Rank
648
Key Stats
Market Cap
$246.7MUSD
23.29B INR
Enterprise Value
$316.95MUSD
29.93B INR
Revenue (TTM)
$184.94MUSD
17.46B INR
EBITDA (TTM)
$23.79MUSD
2.25B INR
Net Income (TTM)
-$1.38MUSD
-130.0M INR
EBITDA Margin
13%
Profit Margin
-0.7%
Forward PE
29.2
PS Ratio
1.3
PB Ratio
1.9
EV/EBITDA
13.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sameer Hiremath open_in_new
Employees
2,062
Founded
1988
Website
hikal.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.1% 0.8% 21% -3.5% -21% -53%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
HIKAL
Hikal Ltd
ISIN: INE475B01022
Shares Out.:
123.301M1 Shares Float: 38.079M2
TV:
SA:
YF:
GF:
BA:
MS:
189.25 INR
Bombay Stock Exchange
MIC: XBOM
524735 (HIKAL)
Hikal Ltd
ISIN: INE475B01022
TV:
SA:
YF:
GF:
BA:
MS:
188.85 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hikal Ltd.

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
18K%
39.1
DIVISLAB
$18.38B
1.73T INR
7K%
70.0
$15.17B
1.43T INR
6K%
63.0
$11.73B
1.11T INR
5K%
19.6
MANKIND
$9.87B
931.67B INR
4K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
4K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
309K%
38.1
JNJ
$547.28B
222K%
26.4
ABBV
$360.63B
146K%
97.4
$318.3B
256.25B CHF
129K%
19.9
AZN
$284.64B
215.59B GBP
115K%
27.6
MRK
$274.03B
111K%
15.1
chevron_leftBack